1. English hepatitis C registry data show high response rates to directly acting anti‐virals, even if treatment is not completed. Issue 1 (22nd May 2020) Authors: Drysdale, Kathryn; Ntuli, Yevedzo; Bestwick, Jonathan; Gelson, William; Agarwal, Kosh; Forton, Daniel; Mutimer, David; Elsharkawy, Ahmed M.; Townley, Ceri; Mahomed, Faizel; Foster, Graham R. Journal: Alimentary pharmacology & therapeutics Issue: Volume 52:Issue 1(2020) Page Start: 168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient. Issue 1 (8th December 2020) Authors: Fordham, Nicholas; Baker, Emma; Forton, Daniel; Klammer, Matthias; Patel, Kamal; Qadir, Dara; Reyal, Yasmin; Willis, Fenella; Koh, Mickey B.C. Journal: EJHaem Issue: Volume 2:Issue 1(2021) Page Start: 143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P49 Adoption of a Clinical Assessment Service in Hepatology. (20th September 2022) Authors: Bratos, Gioia; Ovenden, William; Clark, Sarah; Forton, Daniel; Hughes, Sarah; Singanayagam, Arjuna; Yalcin, Metin Journal: Gut Issue: Volume 71(2022)Supplement 3 Page Start: A69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P56 The evolving role of the Hepatology Pharmacist at St George's Hospital. (20th September 2022) Authors: Boothman, Miss Helen; Reynolds, Kieran; Clark, Sarah; Forton, Daniel Journal: Gut Issue: Volume 71(2022)Supplement 3 Page Start: A73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP08 Expression of the immune checkpoints CD96 and CD226 on ascitic immune cells in patients with decompensated liver disease denotes a more immunosuppressive phenotype. (20th September 2022) Authors: Delo, Joseph; Forton, Daniel; Triantafyllou, Evangelos; Singanayagam, Arjuna Journal: Gut Issue: Volume 71(2022)Supplement 3 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P06 CLIF-C AD score outperforms other prognostic scoring tools in predicting 30-day mortality in patients with acute alcohol-related hepatitis. (20th September 2022) Authors: Gosson, Caroline; Mandour, Omer; Forton, Daniel; Singanayagam, Arjuna Journal: Gut Issue: Volume 71(2022)Supplement 3 Page Start: A34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Expert Opinion on Managing Chronic HCV in Patients with Neuropsychiatric Manifestations. (January 2018) Authors: Forton, Daniel; Weissenborn, Karin; Bondin, Mark; Cacoub, Patrice Journal: Antiviral therapy Issue: Volume 23:Supplement 1(2018) Page Start: 47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Persistent fatigue induced by interferon-alpha: a novel, inflammation-based, proxy model of chronic fatigue syndrome. (February 2019) Authors: Russell, Alice; Hepgul, Nilay; Nikkheslat, Naghmeh; Borsini, Alessandra; Zajkowska, Zuzanna; Moll, Natalie; Forton, Daniel; Agarwal, Kosh; Chalder, Trudie; Mondelli, Valeria; Hotopf, Matthew; Cleare, Anthony; Murphy, Gabrielle; Foster, Graham; Wong, Terry; Schütze, Gregor A.; Schwarz, Markus J.; ... Journal: Psychoneuroendocrinology Issue: Volume 100(2019) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗